Nordicus Partners Corp

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Nordicus Partners Corp
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
Others were interested in
Frequently asked questions
You need to open and fund a Saxo account to buy Nordicus Partners Corp stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for Nordicus Partners Corp (by name) or ‘NORD’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for Nordicus Partners Corp is NORD. You can use this code to find the stock in our platforms and track its price and performance.
Nordicus Partners Corp has its primary listing on NASDAQ (Small cap). You can trade Nordicus Partners Corp with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nordicus Partners Corp is available to trade on SaxoInvestor and SaxoTrader. You can buy Nordicus Partners Corp stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Nordicus Partners Corp or others.